İstatistik
75 metoder i denne familie.
Udvalgte
Accelerated Failure Time (AFT) modelThe Accelerated Failure Time model is a parametric regression approach to survival analysis — formally reviewed and advocated by L. J. Wei in 1992 — in which covariates act as multAdaptiv analyse af konkurrerende risiciAdaptive competing risks analysis combines the Fine-Gray subdistribution hazard framework — which models the cumulative incidence of one cause of failure in the presence of other mAdaptiv Cox Proportional HazardsThe Adaptive Cox Proportional Hazards model extends the classic Cox regression for time-to-event outcomes by adding adaptive LASSO (or related) penalization. It simultaneously estiBayesiansk Kasus-SerieBayesian case series is an observational epidemiological method that applies Bayesian inference to case series data — typically records of patients who experienced both a drug or vBayesiansk case-kontrolstudieA Bayesian case-control study applies Bayesian statistical inference to the classic case-control epidemiological design, formally combining prior knowledge about exposure-disease aBayesiansk Case-Crossover DesignThe Bayesian case-crossover design is a self-matched epidemiological method that estimates the transient effect of a time-varying exposure on the risk of an acute event. Each case
Læsesti
Dette emnes mest refererede grundlæggende metoder, i den rækkefølge de blev udviklet — et godt sted at begynde, hvis du er ny her.
Alle metoder 75
Accelerated Failure Time (AFT) modelAdaptiv analyse af konkurrerende risiciAdaptiv Cox Proportional HazardsBayesiansk Kasus-SerieBayesiansk case-kontrolstudieBayesiansk Case-Crossover DesignBayesiansk kohortestudieBayesiansk analyse af konkurrerende risiciBayesiansk Cox proportional hazardsBayesiansk diagnostisk nøjagtighedsundersøgelseBayesiansk dosis-respons analyseBayesiansk økologisk undersøgelseBayesiansk Kaplan-Meier AnalyseBayesiansk Nested Case-Control StudieBayesiansk fase I klinisk forsøgBayesiansk fase II klinisk forsøgBayesiansk fase III klinisk forsøgBayesiansk fase IV-studieBayesiansk Randomiseret Klinisk UndersøgelseBayesiansk screeningtestevalueringBioækvivalensanalyse (To ensidede tests)Cambridge Depersonalisation Scale (CDS)KOL-vurderingstestClinical Frailty Scale (CFS)Spørgeskema om Fælles FaktorerKonkurrerende Risici OverlevelsesanalyseCox Proportional HazardsCox Proportional Hazards RegressionDeepHitDeepSurvEkologisk studieEmax-model: Farmakodynamisk dosis-respons-analyseShared Frailty Model for Clustered Survival DataHeadache Impact Test-6In Vitro-In Vivo KorrelationFælles model for longitudinelle data og tid-til-hændelses-dataKaplan-Meier overlevelsesestimatorKaplan-Meier-analyseLandmark-analyse for betinget overlevelse og dynamisk prædiktionLog-rank test til sammenligning af overlevelseskurverMatchet analyse af konkurrerende risiciMatched Cox Proportional HazardsMatchet Kaplan-Meier AnalyseMatchet overlevelsesanalyseMeta-analytisk konkurrerende risikoanalyseMeta-analytisk Cox proportional hazardsMeta-analytisk Kaplan-Meier AnalyseMeta-analytisk fase I klinisk forsøgMini-BESTest Balance EvaluationMixture Cure ModelMontreal Cognitive AssessmentMultistatsoverlevelsesmodelMulticenter analyse af konkurrerende risiciMulticenter Cox proportional hazardsMulticenter Kaplan-Meier AnalyseNelson-Aalen Estimator for Kumulativ RisikofunktionPopulationsfarmakokinetikPragmatisk Kaplan-Meier AnalyseProspektiv analyse af konkurrerende risiciProspektiv Cox Proportional HazardsRandom Survival ForestModel for overlevende hændelserRetrospektiv kasuistikRetrospektiv analyse af konkurrerende risiciRetrospektiv Cox Proportional HazardsRetrospektiv økologisk undersøgelse – Historisk analyse på befolkningsniveauRetrospektiv Kaplan-Meier AnalyseRisikojusteret analyse af konkurrerende risiciRisikojusteret Cox proportional hazardsRisikojusteret Kaplan-Meier-analyseRisikojusteret overlevelsesanalyseFleksibel parametrisk overlevelsesmodel (Royston-Parmar)Terapeutisk lægemiddelmonitorering (TDM)Cox Regression med tidsvarierende kovariaterWeibull parametrisk overlevelsesregression